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Introduction
The transcription factor NF-κB is homo- or heterodimers 
formed from a multigene family that encodes fi  ve structure-
  related proteins: p50 (NF-κB1), p52 (NF-κB2), p65 (RelA), c-Rel 
(Rel), and RelB. p50/p65 heterodimer is the predominantly, al-
though not exclusively, detectable form of NF-κB in various 
cells. Normally, NF-κB is sequestered in the cytoplasm in an 
inactive form by binding to the IκB inhibitors. Activation of 
NF-κB requires IκB kinase (IKK) to mediate IκB phosphoryla-
tion, an event leading to IκB degradation and consequently 
freeing NF-κB to translocate into the nucleus for regulating the 
transcription of its target genes. The IKK complex contains two 
catalytic subunits, IKKα and -β, and a regulatory subunit, 
IKKγ. The classical manner for NF-κB activation is mainly de-
pendent on the IKKβ subunit induction (Ghosh and Karin, 
2002; Hayden and Ghosh, 2004).
Induction of the IKK–NF-κB pathway has been observed 
under various cellular stresses. One important role of NF-κB 
activation in these biological processes is to modulate the cel-
lular apoptotic response (Barkett and Gilmore, 1999; Lee et al., 
2000; Baldwin, 2001; De Smaele et al., 2001; Tang et al., 2001; 
Papa et al., 2004a). Many antiapoptotic genes, such as Bcl-XL, 
XIAP (X chromosome–linked inhibitor of apoptosis), IAP1 
and -2, c-FLIP, and Bfl  -1/A1, have κB elements in their pro-
moter or enhancer regions and therefore are inducible by NF-κB 
to protect cells from apoptosis under diverse stimulations 
(Barkett and Gilmore, 1999; Baldwin, 2001). In addition, func-
tional suppression of the JNK cascade, a key intrinsic cell 
death machinery programming cell apoptotic response to envi-
ronmental changes (Davis, 2000; Weston and Davis, 2002; 
Lin, 2003), has recently been proposed as a key mechanism for 
the antiapoptotic action of NF-κB under multiple cellular 
stresses, including the transformation conditions (Bubici et al., 
2004; Nakano, 2004; Papa et al., 2004b). NF-κB suppresses 
the JNK cell death pathway either through the transcriptional 
up-regulation of a set of its targeted genes, such as the caspase 
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C
ross talk between NF-κB and c-Jun N-terminal 
  kinases (JNKs) has been implicated in the cell life 
and death decision under various stresses. Func-
tional suppression of JNK activation by NF-κB has recently 
been proposed as a key cellular survival mechanism and 
contributes to cancer cells escaping from apoptosis. We 
provide a novel scenario of the proapoptotic role of IκB ki-
nase β (IKKβ)–NF-κB, which can act as the activator of the 
JNK pathway through the induction of GADD45α for trig-
gering MKK4/JNK activation, in response to the stimulation 
of arsenite, a cancer therapeutic reagent. This effect of IKKβ–
NF-κB is dependent on p50 but not the p65/relA NF-κB 
subunit, which can increase the stability of GADD45α pro-
tein through suppressing its ubiquitination and proteasome-
dependent degradation. IKKβ–NF-κB can therefore either 
activate or suppress the JNK cascade and consequently 
  mediate pro- or antiapoptotic effects, depending on the 
manner of its induction. Furthermore, the NF-κB p50 subunit 
can exert a novel regulatory function on protein modiﬁ  cation 
independent of the classical NF-κB transcriptional activity.
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inhibitor XIAP, the zinc-fi  nger protein A20, or GADD (growth 
arrest and DNA damage inducible) 45β, which can act as the 
blockers of the JNK cascade (Lee et al., 2000; Tang et al., 
2001; Papa et al., 2004a), or through the transcriptional sup-
pression of GADD45α/γ, a potent activator for the JNK up-
stream kinase MKK4/JNKK1 (Zerbini et al., 2004; Zerbini and 
Libermann, 2005).
Although antiapoptosis represents a fundamental role of 
NF-κB in cellular stress responses, NF-κB is also capable of 
mediating a proapoptotic response in certain circumstances 
(Ghosh and Karin, 2002; Campbell et al., 2004; Hayden and 
Ghosh, 2004; Thyss et al., 2005). It has been shown that UVC 
and some anticancer drugs (daunorubicin/doxorubicin) induce 
NF-κB, especially the p65/RelA subunit, to recruit histone 
deacetylases to the promoter regions of some NF-κB– dependent 
antiapoptotic genes, actively suppress the expression of these 
genes, and promote cell death under these stress conditions 
(Campbell et al., 2004). In the case of UVB radiation, NF-κB 
is induced to selectively up-regulate the expression of the 
  transcription factor and tumor suppressor Egr-1, which in turn 
transcriptionally activates GADD45α to trigger cell apoptosis 
(Thyss et al., 2005). Fas and FasL induction is also implicated 
in the NF-κB–mediated cell apoptotic process (Kasibhatla 
et al., 1998, 1999). Therefore, molecular mechanisms under-
lying the proapoptotic action of NF-κB may be diverse, de-
pending on the nature of the stimuli. Notably, to date, both 
anti- and proapoptotic effects of NF-κB are shown to rely on 
the p65/RelA subunit, which contains a transcriptional activa-
tion domain toward its C terminus (Campbell et al., 2004; 
Papa et al., 2004a; Zerbini et al., 2004; Thyss et al., 2005). 
Little is known about the role of another ubiquitously ex-
pressed subunit, p50, which lacks the transcriptional activa-
tion domain and, thus, does not have the intrinsic ability to 
drive transcription, like its p65 counterpart, in the course of 
the NF-κB–relevant biological processes.
Arsenic is a kind of environmental carcinogen involved in 
the incidence of multiple human cancers (Huang et al., 1999b; 
Simeonova and Luster, 2000; Bode and Dong, 2002; Dong, 
2002). Meanwhile, arsenic-containing compounds have long 
been used as a therapeutic regimen for the treatment of human 
leukemia (Chen et al., 1997). How arsenic engages in the pro-
motion of oncogenesis or performs an anticancer effect still re-
mains an enigma. With regard to its effects in tumorigenesis, 
cell transformation can only be observed with exposure to lower 
concentrations of arsenite. In contrast, high doses of arsenite 
stimulation appear to induce the cytotoxic effect (Huang et al., 
1999a, 1999b; Bode and Dong, 2002; Dong, 2002). Induction 
of JNK activation has been proven to be involved in both 
  arsenite-induced killing and cell transformation (Huang et al., 
1999a, 1999b). However, the roles of the IKKβ–NF-κB signal-
ing pathway in the cellular arsenite response remains controver-
sial, depending on the doses and cell types used (Chen et al., 
2001; Bode and Dong, 2002).
Here, we show that IKKβ–NF-κB can be induced by a 
higher concentration of arsenite to transduce a cell apoptotic 
signal through up-regulation of GADD45α and, subsequently, 
activation of the MKK4–JNK cell death pathway. The NF-κB 
activity in arsenite response is specifi  cally linked to the p50 but 
not the p65/RelA subunit, which mediates the function of in-
creasing GADD45α protein stability through prevention of its 
ubiquitination and proteasome-dependent degradation. Our re-
sults, together with other reports (Papa et al., 2004a, 2004b; 
Zerbini et al., 2004; Zerbini and Libermann, 2005), indicate a 
dual role of NF-κB on the regulation of the intrinsic JNK cell 
death cascade. Most important, for the fi  rst time, to the best of 
our knowledge, we suggest a new model of NF-κB for regulat-
ing cellular apoptotic response through an action independent 
of its transcriptional activity, which is mediated by the p50 but 
not the p65 NF-κB subunit.
Results
IKK𝗃–NF-𝗋B mediates the cellular apoptotic 
response to arsenite exposure
IKKβ is the dominant kinase responsible for NF-κB activa-
tion under various conditions (Hayden and Ghosh, 2004). 
Figure 1.  Arsenite-induced apoptosis is suppressed in IKK𝗃
−/− MEFs. 
(A and B) Cell death of WT and IKKβ
−/− MEFs exposed to different doses 
of arsenite for 24 h (A) or to a single dose of 20 μM arsenite for the times 
indicated (B) were detected by the trypan blue exclusion assay. At least 
500 cells were counted for each group, and results are presented as mean 
± SD from three independent experiments. (C) Flow cytometric analysis for 
the apoptosis of WT and IKKβ
−/− MEFs with or without 24 h of arsenite 
treatment. A representative result is shown. AP represents the percentage 
of the apoptotic cells. (D) WT and IKKβ
−/− MEFs were treated with arsenite 
for 24 h, and the inducible cleavage of both caspase3 and PARP was de-
tected by immunoblot assay. (E) WT and IKKβ
−/− MEFs were exposed to 
2 kJ/m
2 UVB, 4 μM B(a)PDE, or 50 μM H2O2 for 24 h, and cell death was 
monitored by the trypan blue exclusion assay.IKKβ–P50 MEDIATES GADD45α–JNK APOPTOTIC PATHWAY • SONG ET AL. 609
To characterize the roles of the IKKβ–NF-κB pathway in the 
arsenite response, mouse embryonic fi  broblasts (MEFs) derived 
from wild-type (WT) or IKKβ gene knockout (IKKβ
−/−) mice 
were exploited, and their responses to two doses (10 and 20 μM) 
of arsenite stimulations were compared. As shown in Fig. 1 A, 
exposure to 10 μM of arsenite did not cause detectable cyto-
toxic effects to both types of MEFs within 24 h. However, a 
considerable increase in cell death was observed for WT MEFs 
at 24 h under the treatment of 20 μM arsenite, but no increase 
in cell death for IKKβ
−/− MEFs was observed under the same 
conditions, assayed by both the trypan blue staining and fl  ow 
cytometric analysis (Fig. 1, A and C). The difference of cell 
death in response to the 20 μM arsenite stimulation between 
WT and IKKβ
−/− cells was more obvious at 48 h after the treat-
ment, when >54% of cell death was detected for WT MEFs, 
versus only  10% for IKKβ
−/− MEFs (Fig. 1 B). Accordingly, 
the induction of the cleavage of caspase3 and poly (ADP- ribose) 
polymerase (PARP), two indicators of apoptosis (Mullen, 2004), 
was readily detectable in WT MEFs but substantially reduced in 
IKKβ
−/− MEFs (Fig. 1 D). The same cells were also exposed to 
other cytotoxic stimuli, including UVB, benzo-[a]pyrene-7,8-
diol-9,10-epoxide (B[a]PDE), and hydrogen peroxide. In con-
trast to this observation, IKKβ
−/− MEFs showed more sensitivity 
to apoptosis under these stress conditions (Fig. 1 E). These re-
sults suggest that the apoptotic-resistant phenotype of IKKβ
−/− 
MEFs is specifi  cally exhibited under the arsenite stress.
To confi  rm that the IKKβ-dependent pathway is explored 
to transduce a cell death signal in arsenite response, we fi  rst 
showed that effi  cient induction of IKKβ phosphorylation (Fig. 
2 A), NF-κB component (p50 and p65) nuclear translocation 
(Fig. 2 B), and expression of two NF-κB–targeted genes, 
c-Myc and Cox-2 (Fig. 2 C), were readily detectable in WT 
cells but not in IKKβ
−/− cells under 20 μM arsenite exposure, 
indicating that arsenite stimulation has the effect of activating 
the NF-κB pathway, and such an induction is dependent on 
the existence and activity of IKKβ. We next stably expressed 
a dominant-negative IKKβ mutant (IKKβ-KM; Geleziunas 
et al., 1998; Chu et al., 1999; Chen et al., 2001) in WT MEFs 
to block the IKKβ–NF-κB pathway (Fig. 3 A). Meanwhile, an 
HA-tagged IKKβ construct was introduced into IKKβ
−/− 
MEFs to reconstitute the IKKβ–NF-κB pathway. As expected, 
stable expression of IKKβ-KM considerably suppressed the 
arsenite-induced cell death (Fig. 3 B) and PARP cleavage 
(Fig. 3 C) in WT MEFs; however, stable overexpression of 
HA-IKKβ in IKKβ-null MEFs (Fig. 3 D) remarkably sensi-
tized these cells to the arsenite-induced cell death (Fig. 3, E 
and F). Collectively, we propose that induction of the IKKβ–
NF-κB pathway programs a cellular apoptotic response to 
 arsenite  stimulation.
Figure 2. Arsenite-induced  IKK𝗃 activation and NF-𝗋B components (p50 
and p65/RelA) nuclear translocation were blocked in IKK𝗃
−/− MEFs. 
(A) WT and IKKβ
−/− MEFs were treated with 20 μM arsenite for the indi-
cated times, and the activation of IKKβ was detected by immunoblot assay. 
(B) WT and IKKβ
−/− MEFs were treated with 20 μM arsenite for 12 h, and 
the distribution of p50 and p65 in the cytoplasmic and nuclear fractions 
was detected. (C) WT and IKKβ
−/− MEFs were treated as described in B, 
and the expression levels of two NF-κB targeted genes, c-Myc and Cox2, 
in the whole cell extract were detected by immunoblot assay.
Figure 3.  Evidence for the involvement of the IKK𝗃–NF-κB pathway in 
mediating arsenite-induced cell apoptosis. (A) WT cells stably transfected 
with the construct containing dominant-negative kinase mutant of IKKβ 
(FLAG-IKKβ-KM) or the control vector were treated with arsenite for 12 h, 
and the activation of IKKβ was detected. (B) Cells described in A were 
treated with 20 μM arsenite for the times indicated, and cell death was 
measured by the trypan blue viability assay. (C) Cells described in A were 
treated with 20 μM arsenite for 24 h, and the cleavage of PARP was 
  detected. (D) Stable expression of a recombinant IKKβ (HA-IKKβ) in 
IKKβ
−/− MEFs. (E and F) WT, IKKβ
−/−, and the reconstituted IKKβ
−/−(IKKβ) 
MEFs were exposed to 20 μM arsenite for 48 h, and cell death was 
  detected by both the microscopic observation (E) and the trypan blue viability 
assay (F). Error bars indicate mean ± SD.JCB • VOLUME 175 • NUMBER 4 • 2006  610
IKK𝗃–NF-𝗋B mediates arsenite-induced 
apoptosis via JNK activation
Our previous studies have demonstrated that induction of 
JNKs contributes greatly to arsenite-induced cell apoptosis 
(Huang et al., 1999b). We thus tested whether induction of 
IKKβ–NF-κB under arsenite stress has any relevance to JNK 
activation. As shown in Fig. 4 A, induction of marked phos-
phorylation of JNK and its substrate c-Jun in WT MEFs was 
only observed under 20 μM arsenite stimulation, a dose with an 
obvious cytotoxic effect on MEFs (Fig. 1, A–C). The time 
course–dependent experiment indicated that the arsenite-
  induced JNK activation in WT MEFs occurred as early as 6 h 
and was sustained up to 24 h after the treatment (Fig. 4 B). In 
contrast to the observation for WT cells, no obvious induction 
of JNK phosphorylation was found in IKKβ
−/− MEFs in 
both time- and dose-dependent experiments (Fig. 4, A and B). 
  However, effective induction of JNK phosphorylation was still 
observed in IKKβ
−/− MEFs under the UVB radiation (Fig. 4 C), 
suggesting that genetic ablation of IKKβ selectively affected 
the arsenite-induced JNK response. Again, reconstitution ex-
pression of IKKβ in IKKβ
−/− MEFs restored arsenite-induced 
activation of JNKs and c-Jun (Fig. 4 D), whereas  overexpression 
of IKKβ-KM in WT MEFs substantially suppressed arsenite-
induced JNK phosphorylation (Fig. 4 E). These results indicate 
that arsenite-induced JNK activation is dependent on the IKKβ–
NF-κB signaling pathway.
To further confi  rm that IKKβ–NF-κB–mediated JNK ac-
tivation is attributable to the arsenite-induced proapoptotic ef-
fect, a dominant-negative mutant for a JNK-specifi  c upstream 
kinase MKK7 (DN-MKK7; Tang et al., 2001) was stably trans-
fected into WT MEFs to block JNK induction (Fig. 4 F). As 
shown in Fig. 4 (G and H), ectopic overexpression of DN-MKK7 
in WT MEFs partially reduced arsenite-induced JNK pathway 
activation, associated with a remarkable attenuation of cell death 
in these transfected cells.
The requirement of the JNK pathway in mediating arsenite-
  induced apoptosis was also indicated by the observation that 
  arsenite-induced cell death was blocked in the JNK1 and -2 
double gene knockout MEFs (Fig. 5, A and B; Sabapathy et al., 
2004), associated with a considerable suppression of the induc-
ible cleavage of caspase3 and PARP in these MEFs (Fig. 5 C). 
Similar results were also found in JNK1
−/− and JNK2
−/− MEFs 
(unpublished data). Disturbance of mitochondrial function has 
been shown to be involved in JNK-mediated apoptosis under 
certain stresses (Davis, 2000; Tournier et al., 2000; Weston and 
Davis, 2002). We then examined whether this also occurred in 
arsenite response. As shown in Fig. 5 (C and D), a substantial 
down-regulation of the antiapoptotic protein Bcl-2, activation of 
the proapoptotic protein Bid (indicated by its inducible cleavage), 
and the release of cytochrome c from the mitochondria into 
the cytoplasm were observed in WT MEFs upon arsenite treat-
ment, but these events were not detectable in JNK1/2
−/− MEFs 
(Fig. 5, C and D). No obvious changes for other mitochondrial 
components, including Bcl-XL, Bax, Bak, and Smac, were 
found during the arsenite treatment (Fig. 5 D). We thus proposed 
that disturbance of the mitochondrial function might contribute, 
at least in part, to JNK-mediated apoptosis in arsenite response.
IKK𝗃–NF-𝗋B mediates arsenite-induced 
JNK activation via targeting 
MKK4 phosphorylation
MKK4/JNKK1 and MKK7/JNKK2 are the two upstream ki-
nases required for the full activation of JNKs (Davis, 2000; 
Weston and Davis, 2002). We next determined whether NF-κB 
activates JNKs via modulation of these two kinases’ induction 
under arsenite stimulation. As shown in Fig. 6 A, phosphory-
lated MKK7 was present in both WT and IKKβ
−/− MEFs with-
out marked induction before and after the treatment with either 
10 or 20 μM arsenite. However, after treating with 20 μM 
  arsenite, a potent induction of MKK4 phosphorylation was 
found in WT MEFs, but this was not detectable in IKKβ
−/− MEFs. 
Figure 4. IKK𝗃–NF-𝗋B mediates arsenite-induced apoptosis via activa-
tion of the JNK pathway. (A and B) The same cell lysates as in Fig. 2 C (A) 
or Fig. 2 A (B) were examined for JNKs and/or c-Jun activation. (C) WT 
and IKKβ
−/− MEFs were exposed to different doses of UVB for 2 h, and the 
activation of JNKs was detected. (D) WT, IKKβ
−/−, and the reconstituted 
IKKβ
−/−(IKKβ) MEFs were exposed to 20 μM arsenite for 12 h, and the 
activation of JNKs and c-Jun were detected. (E) The same cell lysates as in 
Fig. 3 A were examined for JNK phosphorylation. (F) Stable expression of 
a recombinant dominant-negative MKK7 (HA-DN-MKK7) or dominant-
  negative MKK4 (HA-DN-MKK4) in WT MEFs. (G) WT/DN-MKK7 or the vector 
control stable transfectants were treated with 20 μM arsenite for 12 h, and 
the inducible phosphorylations of both JNKs and c-Jun were analyzed. 
(H) Cells described in G were treated with 20 μM arsenite for different 
  periods of time, and cell death was detected by the trypan blue exclusion 
assay. Error bars indicate mean ± SD.IKKβ–P50 MEDIATES GADD45α–JNK APOPTOTIC PATHWAY • SONG ET AL. 611
The time course–dependent experiment indicated that the dy-
namics of arsenite-induced MKK4 phosphorylation was consis-
tent with that of the JNK induction in WT MEFs (compare Fig. 
6 B with Fig. 4 B), whereas no inducible activation of MKK4 
was observed in IKKβ
−/− MEFs at the indicated time points 
(Fig. 6 B). Furthermore, inhibition of the IKKβ–NF-κB  pathway 
by IKKβ-KM remarkably suppressed arsenite-induced MKK4 
and JNK phosphorylation in WT MEFs, whereas reexpression 
of IKKβ in IKKβ
−/− MEFs restored the response of arsenite-
induced MKK4 phosphorylation in these cells (Fig. 6, C and D). 
These data indicate that the IKKβ–NF-κB pathway signals to 
activate MKK4 under the arsenite response.
To determine whether the induction of MKK4 accounts 
for the arsenite-induced JNK activation and cell apoptosis, DN-
MKK4 was stably introduced into the WT MEFs (Fig. 4 F). 
As indicated in Fig. 6 (E and F), expression of DN-MKK4 inhib-
ited arsenite-induced JNK activation and considerably reduced 
cell death. Based on these results, we conclude that targeting 
induction of MKK4 links IKKβ–NF-κB on JNK functional 
  activation in arsenite response.
IKK𝗃–NF-𝗋B signals the activation of the 
MKK4–JNK cascade by the up-regulation 
of GADD45𝗂 in cellular arsenite response
The GADD45 family proteins (GADD45α, -β, and -γ) were 
proven as binding partner and activator of MEKK4 MAP3K 
in vitro and led to the activation of the downstream target 
JNKs (Takekawa and Saito, 1998). We thus tested whether this 
family protein can act as the downstream effecter of IKKβ–
NF-κB for mediating JNK activation in arsenite response. 
We repeatedly found that arsenite stimulation selectively up-
regulated GADD45α protein levels in WT cells. However, 
no obvious   alteration of the expression of GADD45β and -γ 
was observed under the same conditions (Fig. 7 A). Arsenite-
induced GADD45α up-regulation was impaired in IKKβ
−/− 
MEFs (Fig. 7 A) and was restored in IKKβ
−/− cells by reconsti-
tution of IKKβ (Fig. 7 B). In addition, ectopic overexpression of 
IKKβ-KM in WT MEFs blocked arsenite-induced GADD45α 
accumulation (Fig. 7 C). These results indicate that arsenite 
stimulation up-regulates GADD45α through the IKKβ–NF-κB–
dependent pathway.
To test whether GADD45α up-regulation is responsible 
for JNK activation in arsenite response, we fi  rst transiently 
transfected an HA-tagged GADD45α construct into WT MEFs 
and showed that overexpression of HA-GADD45α actually 
Figure 5.  JNK activation is responsible for arsenite-induced apoptosis via 
mitochondria-dependent pathway. (A) Identiﬁ   cation of JNK1 and -2 ex-
pressions in the WT and JNK1/2
−/− MEFs. (B) WT and JNK1/2
−/− MEFs 
were treated with arsenite for 48 h, and cell death onset was detected by 
the microscopic observation. (C) WT and JNK1/2
−/− MEFs were treated 
with 20 μM arsenite for 24 h, and the inducible c-Jun phosphorylation; 
cleavage of caspase3, PARP, and Bid; and Bcl-2 expression were detected. 
(D) Mitochondrial proteins were prepared from the cells treated as de-
scribed in C. The distribution of cytochrome c, Smac, Bcl-XL, Bcl-2, Bax, 
and Bak in the cytoplasm and mitochondria were monitored. CoxIV was 
detected as a mitochondria-speciﬁ  c marker.
Figure 6. IKK𝗃–NF-𝗋B mediates arsenite-induced JNK activation via tar-
geting modulation of MKK4 phosphorylation. (A and B) The same cell 
lysates described in Fig. 2 (C and A) were detected for the activation of 
MKK4 and/or MKK7. (C) The same cell lysates as in Fig. 3 A were exam-
ined for MKK4 phosphorylation. (D) The same cell lysates as in Fig. 4 D 
were examined for MKK4 activation. (E) WT/vector (the same mass as 
used in Fig. 4 G) and WT/DN-MKK4 stable transfectants were treated with 
arsenite for 12 h, and the activation of JNKs was examined. (F) Cells 
  described in E were treated with 20 μM arsenite for 48 h, and cell death 
onset was detected by microscopic observation.JCB • VOLUME 175 • NUMBER 4 • 2006  612
  induced both MKK4 and JNK phosphorylation in the trans-
fected cell population in the absence of arsenite stimulation 
(Fig. 7 D). We also designed a pair of siRNAs that targeted two 
different regions on the GADD45α mRNA. Stable transfection 
with a combination of these two siRNAs into WT MEFs nearly 
abolished arsenite-induced GADD45α up-regulation, accom-
panied by the blocking of arsenite-induced MKK4 and JNK 
phosphorylation (Fig. 7 E) and a substantial decrease of arsenite-
induced cell death (Fig. 7, F and G). Therefore, we conclude 
that up-regulation of GADD45α is responsible for triggering 
JNK activation and cell apoptosis under arsenite stress.
Arsenite-induced GADD45𝗂 up-regulation, 
MKK4–JNK activation, and cell apoptosis 
are related to the p50 but not the 
p65/relA NF-𝗋B component
We have demonstrated that the NF-κB–GADD45α–MKK4–
JNK pathway is responsible for mediating arsenite-induced cell 
apoptosis. p50 and p65 are two predominant NF-κB compo-
nents expressed in a variety of cell types (Ghosh and Karin, 
2002; Hayden and Ghosh, 2004) and have different roles in reg-
ulating the biological effects of the IKKβ–NF-κB signaling 
pathway under certain stimulation conditions (Abbadie et al., 
1993; Beg et al., 1995; Saccani et al., 2003). To further clarify 
the roles of these two components in arsenite responses, MEFs 
from p50 and p65 gene knockout animals were exploited (Fig. 
8 A). Interestingly, we found that genetic ablation of p65 did not 
affect arsenite-induced GADD45α up-regulation, MKK4 phos-
phorylation, and JNK activation (Fig. 8 B). These cells also 
showed sensitivity to arsenite-induced cell death (Fig. 8 C). 
However, all of the events of arsenite-induced GADD45α up-
regulation, MKK4–JNK activation, and cell apoptosis were 
considerably suppressed in p50
−/− MEFs (Fig. 8, D and E). 
  Furthermore, reconstitution of p50
−/− MEFs with p50 transfection 
(Fig. 8 A) restored arsenite-induced GADD45α up-regulation 
and MKK4–JNK activation (Fig. 8 F), accompanied by the sen-
sitivity of p50
−/−(p50) cells to arsenite-induced apoptosis (Fig. 
8 G). These data disclose a property of the p50 NF-κB compo-
nent in the induction of the GADD45α–MKK4–JNK cell death 
pathway under arsenite stress.
IKK𝗃–NF-𝗋B p50 prevents GADD45𝗂 
proteins from degradation by the ubiquitin–
proteasome pathway in arsenite response
A recent study showed that UV radiation induces  transcriptional 
up-regulation of GADD45α through an NF-κB–dependent 
Figure 7. IKK𝗃–NF-𝗋B mediates arsenite-induced 
activation of the MKK4–JNK cascade through up-
  regulation of GADD45𝗂. (A) The same cell lysates as 
in Fig. 2 A were examined for the expression levels of 
GADD45α, -β, and -γ. (B) WT, IKKβ
−/−, and the re-
constituted IKKβ
−/−(IKKβ) MEFs were exposed to ar-
senite for 12 h, and the expression level of GADD45α 
was detected. (C) The same cell lysates as in Fig. 3 A 
were used to examine the expression level of 
GADD45α. (D) WT MEFs were transiently transfected 
with the expression plasmid of GADD45α (HA-
GADD45α) or the control vector. Cells were harvested 
36 h later, and the activation of MKK4 and JNKs 
  under overexpression of GADD45α was detected. 
(E) WT MEFs were cotransfected with the mixture of 
two GADD45α siRNA constructs or the scrambled 
control siRNA constructs. The corresponding stable 
transfectants were treated with different doses of 
  arsenite for 12 h, and the activation of MKK4 and 
JNKs was detected. (F and G) GADD45α siRNA or 
the control siRNA stable transfectants were treated 
with different doses of arsenite for 48 h, and the cell 
death was detected by either direct microscopic ob-
servation (F) or trypan blue exclusion assay (G). Error 
bars indicate mean ± SD.IKKβ–P50 MEDIATES GADD45α–JNK APOPTOTIC PATHWAY • SONG ET AL. 613
  pathway (Thyss et al., 2005). Unlike the p65 component, the 
p50 subunit of NF-κB does not possess the transcriptional ac-
tivity for lack of the transactivation domain (Ghosh and Karin, 
2002; Hayden and Ghosh, 2004). This implies that the induc-
tion of GADD45α observed in the arsenite response may be 
mechanically different to that in the UV radiation.   Supporting 
this prediction, the RT-PCR assay showed that GADD45α 
mRNA was constitutively expressed in the resting WT MEFs 
and its expression levels did not exhibit detectable change over 
8 h of arsenite treatment; however, up-regulation of GADD45α 
protein levels was detected as early as 2 h and, more signifi  cant, 
at 4 h after arsenite stimulation (Fig. 9 A). As a control, we 
observed that the up-regulation of GADD45α mRNA and its 
protein levels under UVR exhibited the consistent time course–
dependent response (Fig. 9 B). This fi  nding suggests that the 
induction of GADD45α in arsenite response might occur at the 
posttranscriptional level, most possibly by the modulation of 
the protein stabilities. To test this hypothesis, WT MEFs were 
treated with MG132, an established inhibitor of protein deg-
radation by disruption of the proteasome system (Nandi et al., 
2006). As indicated in Fig. 9 C, similar to that of the arsenite 
stimulation, MG132 treatment resulted in a remarkable accu-
mulation of GADD45α proteins. Meanwhile, when the culture 
was withdrawn from MG132 and subjected to the treatment of 
cyclohexamide (CHX), a protein synthesis inhibitor, to block the 
de novo production of proteins, the preaccumulated GADD45α 
by MG132 could undergo a gradual degradation with the reas-
sembly of the proteasome system (Fig. 9 C). MG132 treatment 
also resulted in GADD45α protein accumulation in IKKβ
−/− 
and p50
−/− MEFs, although arsenite failed to accumulate this 
protein in both cells (Fig. 9 D). These results together demon-
strate that the expressed GADD45α is actively subjected to a 
proteasome-dependent degradation process in resting cells, and 
such a process is blocked in arsenite response via the IKKβ–
p50–dependent pathway.
Ubiquitination is the common mechanism for   dictating 
proteins into proteasome-dependent degradation (Nandi et al., 
2006). We next determined whether arsenite induces GADD45α 
accumulation in WT MEFs by suppressing its   ubiquitination. 
GADD45α was immunoprecipitated with specifi  c anti-GADD45α 
antibodies, and its ubiquitination status was analyzed with 
anti-ubiquitin antibodies. As shown in Fig. 9 E (left), only 
a weak ubiquitin signal was detected in the sample of un-
treated WT cells. This result was predictable, as there was little 
GADD45α protein present in these resting cells because of 
its rapid degradation. However, a strong ubiquitin signal was 
Figure 8.  The effect of NF-𝗋B on mediating arsenite-
induced activation of the GADD45𝗂–MKK4–JNK 
cascade and cell apoptosis is related to the p50 but 
not the p65/RelA subunit. (A) Identiﬁ  cation of p50 
and p65/RelA expression in the WT, p65
−/−, 
p50
−/−, and p50
−/− (p50) MEFs. (B) p65
+/+ and 
p65
−/− MEFs were treated with different doses of 
arsenite for 12 h, and the induction of GADD45α 
expression, MKK4, and JNK phosphorylation were 
detected. (C) p65
+/+ and p65
−/− MEFs were ex-
posed to 20 μM arsenite for 24 h, and cell death 
onset was detected with microscopic observation. 
(D) p50
+/+ and p50
−/− MEFs were treated with ar-
senite as described in B, and the same immunoblot 
was preformed. (E) p50
+/+ and p50
−/− MEFs were 
treated with different doses of arsenite for 48 h, and 
cell death was analyzed by the trypan blue exclu-
sion assay. (F) WT, p50
−/−, and the reconstituted 
p50
−/−(p50) MEFs were exposed to 20 μM arsenite 
for 12 h, and the expression of GADD45α and 
the activation of MKK4 and JNKs was detected. 
(G) Cells described in F were exposed to arsenite 
for 48 h, and the apoptotic cell death was detected 
with microscopic observation.JCB • VOLUME 175 • NUMBER 4 • 2006  614
detected in the lane for MG132-treated cells, indicating that the 
accumulated GADD45α protein by MG132 is highly ubiqui-
tinated. Interestingly, the ubiquitin signal for GADD45α in the 
arsenite-treated cells was almost as weak as that in the untreated 
control sample, although its amount in these cells is the same 
as that in the MG132-treated cells, suggesting that the accumu-
lated GADD45α by arsenite stimulation is less ubiquitinated. 
The effect of arsenite on suppressing GADD45α ubiquitina-
tion was also manifested in the MG132/arsenite double-treated 
cells, in which the ubiquitin signal for GADD45α was sub-
stantially decreased as compared with that in cells treated with 
MG132 alone. The ubiquitination status of GADD45α was 
also analyzed in IKKβ
−/− and p50
−/− MEFs (Fig. 9 E, middle 
and right). As expected, MG132 treatment also accumulated 
large amounts of highly ubiquitinated GADD45α in both cells. 
  However, the effect of arsenite on suppressing GADD45α ubiq-
uitination, which was observed in WT MEFs, was not exhibited 
in both gene knockout cells, indicated by the same high levels 
of GADD45α ubiquitination in MG132/arsenite and MG132-
treated cells. These results demonstrate that arsenite stimula-
tion provokes a response to suppress GADD45α ubiquitination, 
depending on the IKKβ–p50 signaling pathway.
To further clarify whether the action of IKKβ–p50 on pre-
venting GADD45α degradation under arsenite stimulation is 
through preventing this protein from ubiquitination or by medi-
ating a process of deubiquitinating the ubiquitinated proteins, 
we designed an experimental system in which the MEFs were 
pretreated with MG132 to accumulate a certain amount of 
GADD45α proteins in vivo. After the pretreatment, MG132 was 
removed from the medium and the protein synthesis inhibitor 
Figure 9. IKK𝗃–NF-𝗋B p50 mediates arsen-
ite’s effect on inhibition of ubiquitination and 
degradation of GADD45𝗂 proteins. (A and B) 
WT cells were treated with 20 μM arsenite (A) 
or 2 kJ/m
2 UVB (B) for the times indicated, and 
the inducible expression of GADD45α mRNA 
and proteins were detected by PT-PCR and im-
munoblot assay, respectively. Data from one of 
the two independent experiments are shown, 
and the relative expression levels of GADD45α 
mRNA normalized to the β-actin control is also 
presented. (C) WT cells were either treated 
with 10 μM MG132 for the indicated times 
(top) or pretreated with 10 μM MG132 for 4 h, 
followed by exposure to 10 μM CHX for the 
different period of times after withdrawal of 
MG132 (bottom). Immunoblot assay was per-
formed to detect the expression of GADD45α 
proteins. (D) WT, IKKβ
−/−, and p50
−/− MEFs 
were exposed to 20 μM arsenite or 10 μM 
MG132 for 12 h, and the expression of 
GADD45α in individual cells was detected. 
(E) WT, IKKβ
−/−, and p50
−/− MEFs were 
treated with 20 μM arsenite, 10 μM MG132, 
or the combination of these two reagents for 
12 h, and the whole cell extracts were immuno-
precipitated with anti-GADD45α antibody. 
Ubiquitinated GADD45α was detected with 
anti-ubiquitin antibody. Input of the proteins 
subjected to immunoprecipitation is also 
shown. (F) WT, IKKβ
−/−, p50
−/−, and the cor-
responding reconstituted MEFs, as well as 
p50-speciﬁ   c siRNA stably transfected WT 
cells, were pretreated with 10 μM MG132 
for 4 h and exposed to 10 μM CHX in the 
  absence or presence of 20 μM arsenite for 
the times indicated after removal of MG132. 
GADD45α expression was detected by immuno-
blot assay. (G) WT MEFs were treated with 
20 μM arsenite for the times indicated, and 
the whole cell extracts were immunoprecipi-
tated with anti-p50 antibody. The immunopre-
cipitated samples were detected with anti-p50, 
-IKKα, and -IKKβ antibodies, respectively. Input 
of the proteins subjected to immunoprecipitation 
is also shown. (H) Models of different mecha-
nisms of NF-κB in the cell life and death control 
under diverse conditions mediated by GADD45 
family members and the JNK pathway.IKKβ–P50 MEDIATES GADD45α–JNK APOPTOTIC PATHWAY • SONG ET AL. 615
CHX was added to the cells alone or in combination with arsenite. 
In this way, we were able to analyze the effect of arsenite on 
the dynamic degradation of the preubiquitinated GADD45α 
proteins during the course of the reassembly of the proteasome 
system in vivo. As shown in Fig. 9 F, the preaccumulated 
GADD45α proteins disappeared in all tested cells within 12 h 
after removal of MG132 in the absence of arsenite. With arse-
nite stimulation, GADD45α proteins remained stable at 12 h 
after withdrawal of MG132 in WT and p65
−/− MEFs. However, 
almost no GADD45α proteins were detectable at this time point 
in either IKKβ
−/− or p50
−/− MEFs under the same conditions. 
Again, reintroduction of IKKβ and p50 into the according gene 
knockout cells restored the effect of arsenite on preventing 
GADD45α degradation. In addition, suppression of p50 expres-
sion by its specifi  c siRNA (unpublished data) partially disrupted 
the effect of arsenite in WT MEFs. Based on these results, we 
propose that IKKβ–p50 might exert an effect for mediating the 
deubiquitination of GADD45α under the arsenite response, and 
this might contribute, at least in part, to the phenomenon of the 
arsenite-induced GADD45α up-regulation.
Discussion
The IKKβ–NF-κB signaling pathway transmits signals essen-
tial for cell survival in a variety of physiological and pathologi-
cal processes (Hayden and Ghosh, 2004). Deregulation of this 
signaling pathway has been directly implicated in the evasion of 
the apoptotic responses of many human cancers. As a result, 
targeted inhibition of the IKKβ–NF-κB pathway has been pro-
posed as a strategy for the development of new anticancer drugs 
(Karin et al., 2002). Interestingly, it has recently been demon-
strated that this signaling pathway can also be induced to exert 
proapoptotic effects in response to some apoptotic inducers 
(Kasibhatla et al., 1998, 1999; Campbell et al., 2004; Thyss 
et al., 2005). Although this fi  nding raises caution regarding the 
rationale of the proposed use of IKKβ–NF-κB inhibitors in 
combination with other anticancer drugs in a clinical setting, it 
also provides an alternative for targeting IKKβ–NF-κB for cancer 
therapy and chemoprevention. Therefore, identifi  cation of the 
conditions and the according mechanisms for converting the anti-
apoptotic role of this signaling pathway to the proapoptotic 
  action in cancer cells will be of medical signifi  cance.
Arsenite was regarded as both a carcinogen and tumor-
therapeutic agent because of its ability to mediate cellular apop-
totic or transformation effects under different conditions (Chen 
et al., 1997; Bode and Dong, 2002; Dong, 2002). Our previous 
studies have disclosed that a low dose of arsenite (1.25–5 μM) 
is capable of promoting the cell cycle by the induction of cyclin 
D1 expression through the IKKβ–NF-κB pathway (Ouyang 
et al., 2005). However, the precise mechanism of arsenite on the 
tumor therapeutic effect is not well clarifi  ed. In this study, we 
demonstrate that at a higher dose (20 μM) arsenite can induce 
an activity of the IKKβ–p50 NF-κB complex to program cell 
apoptosis via triggering the GADD45α–MKK4–JNK cell death 
cascade (Fig. 9 H). These novel fi   ndings demonstrate that 
IKKβ–NF-κB has the intrinsic competence to directly turn on 
the cell death program through the activation of JNK cascade 
under stress conditions and add a new content to the cross talk 
between NF-κB and JNK signaling pathways in cell life and 
death decisions (Bubici et al., 2004; Nakano, 2004; Papa et al., 
2004b). As suppression of the JNK activation by NF-κB is es-
sential for cancer cell survival (Zerbini et al., 2004; Zerbini and 
Libermann, 2005), our fi  nding that arsenite is capable of sub-
verting the inhibitory effect of NF-κB on JNK activation may 
be of medical importance. It merits further elucidation as to 
whether such a mechanism underlies the effect of this reagent in 
cancer therapy.
How NF-κB can be induced to functionally suppress or 
activate the JNK cell death pathway is an interesting question. 
Previous reports (Papa et al., 2004a; Zerbini et al., 2004) and 
the data in this study suggest that the GADD45 protein family 
(GADD45α, -β, and -γ) may serves as a key modulator for 
functionally linking IKKβ–NF-κB to the JNK pathway. In this 
model (Fig. 9 H), by differential regulation of GADD45 family 
members (up- or down-regulated), NF-κB can be induced to 
suppress or activate the JNK cell death pathway, thereby exert-
ing its pro- or antiapoptotic effects according to the nature of 
the stresses. Our results have disclosed the predominant role of 
GADD45α in arsenite-induced cell death response. In addition, 
previous data have shown that suppression of GADD45α and -γ 
contributed to cancer cell survival, whereas induction of 
GADD45β antagonized TNFα-induced killing (Fig. 9 H; Papa 
et al., 2004a; Zerbini et al., 2004). These results suggest that 
GADD45α and -γ mainly contribute to the NF-κB–mediated 
cell death effect, whereas GADD45β appears to involve NF-κB–
dependent cell survival.
Interestingly, we noticed that all of the previous studies re-
garding the regulatory effect of NF-κB on GADD45 expression 
are exclusively dependent on the transcriptional activity of NF-κB, 
such as the transcriptional suppression on GADD45α and -γ 
by constitutively active NF-κB in cancer cells and the transcrip-
tional induction of GADD45β by NF-κB in response to TNFα 
stimulation. In addition, NF-κB activity in these responses is me-
diated by the cooperative action of the p65 and p50 subunits 
(Papa et al., 2004a; Zerbini et al., 2004). In contrast, we demon-
strate that the role of NF-κB on mediating the arsenite-induced 
GADD45α up-regulation is by preventing this protein from the 
ubiquitin–proteasome–dependent degradation, instead of the 
transcriptional induction of the GADD45α gene. Furthermore, 
this effect of NF-κB only relates to the p50 but not the p65/RelA 
subunit. Therefore, our data, for the fi  rst time, has provided a 
strong evidence for a new function of the NF-κB p50 subunit, 
which is independent of the classical NF-κB transcriptional activ-
ity but relates to the posttranslational modifi  cation of a protein.
GADD45 is originally described as a p53-dependent and 
stress-inducible gene that also can be regulated by many other 
transcription factors (Wang et al., 1999; Zerbini et al., 2004; 
Thyss et al., 2005). In addition, recent evidence suggests that 
protein ubiquitination represents another way for GADD45 
regulation (Leung et al., 2001). Here, we showed that arsenite-
induced GADD45α accumulation through preventing this protein 
from ubiquitination-dependent degradation, further emphasizing 
the importance of this kind of mechanism on the functional con-
trol of GADD45 family members.JCB • VOLUME 175 • NUMBER 4 • 2006  616
The mechanism responsible for the p50-mediated 
GADD45α modifi  cation is currently unknown. Clearly, it has 
some relevance to the presence of IKKβ protein, indicated by 
the similar manner of the changes on ubiquitination, degrada-
tion, and accumulation of GADD45α proteins under arsenite 
stimulation in IKKβ
−/− and p50
−/− MEFs (Fig. 9, E and F). 
How IKKβ functionally links to the NF-κB p50 subunit in arse-
nite response remains unclear. However, we have observed that 
a transient interaction between IKKβ and p50 can be induced 
by arsenite in WT MEFs in the coimmunoprecipitation assay, 
and the time course–dependent response of the IKKβ–p50 com-
plex formation (between 1 and 4 h after arsenite stimulation; 
Fig. 9 G) is consistent with the appearance of the accumulated 
GADD45α proteins (2–4 h after arsenite stimulation; Fig. 9 A). 
In contrast, there is no obvious interaction between IKKα and 
p50 under the same conditions (Fig. 9 G). This result provided 
us with an important clue suggesting that the inducible interac-
tion between IKKβ and p50 by arsenite might confer a novel 
property to this putative complex for suppressing GADD45α 
ubiquitination. Because arsenite stimulation increased the ubiq-
uitination of total cellular proteins (unpublished data) while 
  selectively decreasing the GADD45α ubiquitination level, we 
proposed that the most probable action of IKKβ–NF-κB p50 is 
to target GADD45α-specifi  c E3 ubiquitin ligase or the cellular 
deubiquitination enzymes. The functional link between IKKβ 
and p50 and the possible mechanism responsible for the IKKβ–
p50–containing complex on regulating GADD45α ubiquitina-
tion and degradation are currently under investigation.
In summary, this study demonstrates for the fi  rst time that 
the IKKβ–NF-κB signaling pathway can transduce the apop-
totic signal through eliciting the intrinsic GADD45α–MKK4–
JNK cell death route and provides a novel scenario for the 
implication of the cross talk between these two master path-
ways in the cell life and death decisions encountering diverse 
stresses. Furthermore, we disclosed a new function of NF-κB 
p50 subunit, which can act as a critical regulator of the ubiquitin–
proteasome–dependent modifi  cation of GADD45α. Our study, 
together with other recent fi  ndings, clearly suggests the exis-
tence of different mechanisms underlying the NF-κB pathway. 
Elucidation of these issues should shed important insight on the 
understanding of how NF-κB integrates diverse stimuli to gen-
erate a unifi  ed outcome suitable for a specifi  c situation, a ques-
tion raised in the current fi  eld of NF-κB investigation.
Materials and methods
Plasmids, antibodies, and other reagents
The plasmid expressing the kinase mutant of IKKβ (Flag-IKKβ-KM) was a 
gift from H. Nakano (Juntendo University, Tokyo, Japan; Nakano et al., 
1998). The plasmid expressing HA-tagged full-length GADD45α (HA-
GADD45α) was described in a previous study (Wang et al., 1999). The 
plasmid containing p50 cDNA was provided by J. Ye (Louisiana State Uni-
versity, Baton Rouge, LA). The plasmids expressing dominant-negative 
MKK4 (HA-DN-MKK4) or dominant-negative MKK7 (HA-DN-MKK7) and 
the full-length IKKβ (HA-IKKβ) were described in a previous study (Tang 
et al., 2001). The antibodies against phospho-IKKα/β, IKKα, IKKβ, phospho-
JNK, JNK, phospho-MKK4, MKK4, phospho-MKK7, MKK7, phospho-c-Jun, 
c-Jun, caspase3, PARP, Bcl-2, Bcl-XL, Bax, and Bak were purchased from 
Cell Signaling Technology. The antibodies against GADD45α, -β, and -γ; 
c-Myc; p65; p50; Bid; and the agarose-conjugated anti-p50 antibody 
were obtained from Santa Cruz Biotechnology, Inc. Anti–cytochrome c and 
Smac antibodies were purchased from BD Biosciences. Anti-HA and ubiq-
uitin antibodies were purchased from Upstate Biotechnology; anti-FLAG 
and anti–β-actin antibodies were obtained from Sigma-Aldrich; and anti-
Cox2 antibody was purchased from Cayman Chemical. MG132 and CHX 
were purchased from Calbiochem.
Cell culture and transfection
IKKβ
−/− MEFs were a gift from M. Karin (University of California, San 
  Diego, La Jolla, CA; Tang et al., 2001). The p50
−/− and p65
−/− MEFs 
and their corresponding WT MEFs were provided by J. Ye. The JNK1/2
−/− 
MEFs were provided by K. Sabapathy (National Cancer Center, 
  Singapore; Sabapathy et al., 2004). The WT and the gene knockout MEFs 
were maintained in DME (Calbiochem) supplemented with 10% FBS, 1% 
penicillin/streptomycin, and 2 mM L-glutamine (Life Technologies) at 
37°C. Cell transfections were performed with Lipofectamine reagent (Invi-
trogen) according to the manufacturer’s instruction. For stable transfec-
tion, cultures were subjected to either hygromycin B or G418 drug 
selection, and cells surviving from the drug selection were pooled as sta-
ble mass. These stable transfectants were cultured in the selective drug-
free medium for at least two passages before used for according 
experiments. For transient transfection, cells were harvested at 36 h after 
transfection for immunoblot analysis.
Construction of GADD45𝗂 siRNA expression plasmids
The two sequences, 5′-gatcctgccttaagtcaa-3′ and 5′-agtcgctacatggat-
cagt-3′, on GADD45α mRNA were selected by the siRNA Target Finder 
(http://www.ambion.com/techlib/misc/siRNA_ﬁ  nder.html; Ambion) as 
siRNA target sites and were expressed by using the GeneSuppressor 
system (Imgenex). The constructs containing the corresponding scram-
bled target sequences were used as controls. The established constructs 
were either separately transfected or cotransfected into WT cells for 
  stable expression.
Cell death analysis
The arsenite-induced cell death was determined by trypan blue exclusion 
assay and ﬂ  ow cytometric analysis after propidium iodide staining of the 
nuclei. For the live cell microscopy, the images were taken with an in-
verted microscope (CKX41; Olympus) equipped with the achromatic ob-
jectives (10×; NA 0.25; working distance 8.8 mm) and the digital camera 
(DP12-2; Olympus) at room temperature. The images were analyzed   using 
Photoshop (Adobe).
Western blot
Whole cell extracts were prepared with the cell lysis buffer (10 mM Tris-
HCl, pH 7.4, 1% SDS, and 1 mM Na3VO4). Cytoplasmic and nuclear 
proteins were prepared with Cellytic nuclear extraction kit (Sigma-Aldrich) 
following the manufacturer’s protocols. The mitochondrial proteins were 
prepared with the Mitochondria isolation kit for mammalian cells (Pierce 
Chemical Co.) following the manufacturer’s protocols. Protein concentra-
tions were determined by the protein quantiﬁ   cation assay kit (Bio-Rad 
Laboratories). 30 μg of proteins were resolved by SDS-PAGE, probed with 
the indicated primary antibodies, and incubated with the AP-conjugated 
second antibody. Signals were detected by the enhanced chemiﬂ  uores-
cence Western blotting system as described in our previous reports (Huang 
et al., 1999a; Li et al., 2004). The images were acquired by scanning 
with the phosphoimager (model Storm 860; Molecular Dynamics) at 
room temperature.
Immunoprecipitation
For ubiquitination studies, cells were treated with 10 μM MG132, 20 μM 
arsenite, or the combination of these two reagents for 12 h and then lysed 
in the cell lysis buffer (1% Triton X-100, 150 mM NaCl, 10 mM Tris, pH 
7.4, 1 mM EDTA, 1 mM EGTA, 0.2 mM Na3VO4, 0.5% NP-40, and com-
plete protein inhibitors mixture tablet) on ice. 0.5 mg total lysate was pre-
cleared by incubation with Protein A/G plus-agarose (Santa Cruz 
Biotechnology, Inc.) and incubated with 2 μg anti-GADD45α monoclonal 
antibody for 2 h at 4°C. 40 μl Protein A/G plus-agarose were added into 
the mixture and incubated with agitation for an additional 4 h at 4°C. The 
immunoprecipitated samples were washed with the cell lysis buffer and 
subjected to the Western blot assay with the anti-ubiquitin antibody. To de-
tect putative p50 binding proteins, cell lysates from arsenite-treated WT 
cells were incubated with agarose-conjugated anti-p50 antibody, and the 
immunoprecipitated samples were subjected to the Western blot assay with 
anti-IKKα and -IKKβ antibodies, respectively.IKKβ–P50 MEDIATES GADD45α–JNK APOPTOTIC PATHWAY • SONG ET AL. 617
RT-PCR
Total RNA was extracted with Trizol reagent (Invitrogen), and cDNAs were 
synthesized with ThermoScript RT-PCR system (Invitrogen). Two oligonucle-
otides (5′-atgactttggaggaattctcg-3′ and 5′-cactgatccatgtagcgacct-3′) were 
used as the speciﬁ   c primers to amplify mouse GADD45α cDNA. The 
mouse β-actin cDNA fragments were ampliﬁ  ed by the primers 5′-gacgat-
gatattgccgcact-3′ and 5′-gataccacgcttgctctgag-3′.
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